Aligos Therapeutics, Inc. Common Stock ALGS
$7.65
+36.85%
at last close
Market Cap$47.77 million
P/E Ratio—
Div Yield—
Volume615.8K
52-Week Range
$3.98$13.69
Key Stats
- Today's Range
- $5.73 – $7.71
- 50-Day Range
- $3.98 – $7.71
- 52-Week Range
- $3.98 – $13.69
- Volume
- 616K shs
- Average Volume
- 268K shs
- Market Cap
- $47.77 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 36.27%
- Days to Cover
- 4.10
About Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Related Stocks
Compare head-to-head: ALGS vs AMGN·ALGS vs HALO·ALGS vs RGEN·ALGS vs IMVT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.